 recording. There we go. All right, and I suspect we'll have folks joining the call as we get into the hour here. But again, thanks everyone for joining us. This is our third in a sort of an ongoing special topic series regarding the COVID virus. Of course, we're all very aware of the pandemic that we're sort of working our way through. And so this organization, Linux Foundation, of course, Hyperledger particularly, and then this healthcare specialist group especially, has been over the past month and a half really focusing on talking through some ways to help drive solutions to this pandemic. And so the format for again for this special topic meeting will sort of walk through. First and foremost, I want to just let everyone know that we are recording this. And so please be aware of that and be sensitive that as well. We do have a Linux Foundation antitrust policy that I just want to make sure that everyone's aware of. Please review that. There's a URL there for details on our antitrust policy. In short, it means please be a good person. Don't share any information that you think to be IP. This is an open source open community meeting. And so be aware of that. We do have quite a number of folks on the call. And I suspect we'll be gathering them collecting them along the way. Just let's see. Well, let's see if we can walk through this very quickly. So anyone on the call want to introduce themselves just very briefly say hello and tell us a little bit about yourself. Go ahead, Indira. Can you hear me? Yes, we can. Good morning. Good morning, everybody. I'm Dalingian from Austin, Texas. I just kind of accidentally saw this in LinkedIn and I'm happy to join this call. And I have been an IT professional in global IT roles and five out of seven continents in the last 25 plus years. And my last role was with the Huffman La Roche biotech pharma company five and a half years in global IT leadership role, so in medical device industry. And then since I left Roche in the last two years, and I have been heavily invested in learning about blockchain and especially focused on healthcare. I'm very passionate about blockchain, healthcare intersection, learning a lot about hyperlogy as well. So I'm glad to be a part of this group and I intend to join this group and come to regular meetings and learn more and find opportunity if I can contribute anyway. Oh, excellent. Well, great to have you, Indira. And fantastic that you have a great background in the healthcare space and particularly happy to have your interest sort of getting exercised here. So great, great to join us. I would, and this is true for everyone that's really very new to this, to this special interest group. Feel free to take a look on our wiki page here because this, even though this is a special topic meeting, we do get together every two weeks as a large group. This is a membership of about a thousand members. We're clearly international and our focus really is looking at ways to solve problems in the healthcare industry using blockchain technologies. And so this is really a great opportunity for anyone to sort of get sort of get involved. So thanks very much. Em Novak, go ahead and please unmute yourself. Oh, we muted down. Yep, you're good. Thank you. Good morning. So good morning. This is Michael Novak. I'm in beautiful downtown Arlington, Virginia and working with a company called Simba Chain. We focus on smart contracts and I'm excited to be here. I've been involved with blockchain in general for the last five or six years. A member of the government blockchain association work with smart city councils and work with a variety of other interest groups that are focused on how we can use web 30 technology to improve things like the processes and workflows in healthcare. Excellent. Great to have you on the call. And again, welcome. And yeah, we'd love to have you get more involved in this special interest group and hyper ledger in general. It's a great organization. And again, we are open source open community. So you're clearly free to get involved at a level that you feel comfortable with. Thanks for joining us. And I was lucky real quick. I was lucky. I attended the hyper ledger forum just before COVID brought the dark skies upon us. So I was very excited to get involved very closely with the presentations on dids and the applications. Oh, yeah. Oh, excellent. Oh, very good. Good to hear. Well, again, welcome. Great to have you Jeff. This is I'm Jeff Stolman. I live outside of Philadelphia. And I've been part of this group for a long time, but I have been absent for probably a year and a half just because of the work schedule I'm on. But I'm very interested in developing tools and solutions in blockchain and actually have been on the side lately working on a way to get the right to be forgotten that can be appended to any blockchain. Yeah, excellent, Jeff. And Jeff, you're sort of a long, long time member. You've been around since the inception of really of the organization. So great to have you back in the fray, Jeff. And good to hear from you again. Thank you. Anisu. Hello. My name is Anisu. I've been involved in the type of ledger for a while, but this is my first time participating in this call. We start up that is doing prepayment claims verification. But within that, there's a lot of other interesting things as well that is to do with COVID that we are learning is we are trying to implement this with a pilot scheduled in September with Blue Cross Blue Shield of North Carolina. And then we'll get a chance to talk about it during the presentation. But this is my first time and we're, you know, we're also a startup. So just doing the the the introduction before the presentation so that doesn't cut into my time. Okay, well, thanks, Anisu. And yeah, and Anisu will be speaking. He's one of our guest speakers for for the day. So great to have you on the call. Thank you so much. Anyone else want to introduce themselves? Hi, good morning, everyone. This is Ankit Jen. I've joined the general meeting time and time again. I've tried to be more involved in it, but I I work with Ravish on the pair subgroup, and I'm filling in for him today. Excellent. And then when we get into community announcements, I'll probably circle back around to you and we can talk a little bit more about what this with the pair subgroup is up to very quickly. Yeah, absolutely. Thank you. Thank you. All right. Anyone else before we get moving? Excellent. Well, thanks, everyone. Again, and because we do have quite a quite a few new members or visitors joining us, I do want to mention we do have a membership directory. Feel free to jump on and make make some edits, introduce yourselves. It's a great way to connect sort of person to person. And we sort of continue to grow this out over time. And it's been a great way to sort of keep people sort of in touch outside of these general meetings. These general meetings happen every two weeks. As well, we also have three separate subgroups. And those subgroups really are sort of boots on the ground. They tend to be very, very focused on applications in the healthcare industry as it relates to our patient subgroup, our payer subgroup, which clearly both of those are focused on those areas of interest, as well as our interoperability subgroup. And so we've got three great subgroups that are very active and they tend to operate about that same same sort of cadence every couple of weeks, they get together. So we're going to move forward and talk a little bit about community announcements and also feel free to sort of interject if you have something else that you'd like to add. But I do want to talk a little bit about our mentorship program. This is, I believe, our fourth year for the Mentorship Program. It's really intended for students and young people who are just getting out of school and finding a way to get connected into the community here. That is, it's a great opportunity. We've got quite a number of projects to get involved in. So if you are or know someone who's a student, feel free to get involved through that webpage. The application deadline is coming up. It's about a week out. So you may want to sort of get moving if you have an expressed interest in getting involved in that program. Okay, and then I do have a special note from our payers subgroup. Ankit is on the call. In short, we're through that subgroup, we're spending up a new pharmacy POC that's starting next week. It'll be utilizing hyperlitra fabric, which I think most people are familiar with, as well as Joggot's low code platform, which, Ankit, do you want to talk a little bit more about this POC? And be sure to unmute yourself. And perhaps we may have missed Ankit. I see him, but I just, I don't see him talking. So, oh, there we go. Excellent. Good, good, good. Double mute. The hazards. Yes. Hey, everybody. So we've been making, we've been having some good contributions, making some good progress on the payers subgroup. The last three sessions, we discussed the use case of prescription management and how it relates to both fraud abuse and the convenience of users or, you know, of patients that you can, or Vicky and the use case has been published on a PowerPoint slide. We keep adding to it. We have been engaging with the patient subgroup to integrate with the patient consent part of it. So that's the work that we have been doing. Now, next week's session, next Friday at one Eastern Standard, we have a very important session because we're doing a, we're doing a working session where we will show the Fabcar example. We'll show how to create an application around it without coding. So if you're technical users or you're not non-technical users, or if you know anybody who'd be interested in it, please feel free to forward them our email, our, you know, our connection details, et cetera. And we're really just trying to get more and more people in to show them how easily we can tap into blockchains without having to code these around and really leverage blockchains for, for, for its strength purpose. Excellent. Well, very good. Thank you for that, Ankit. And again, patient subgroup, we have a, we have a link to that here. Again, it's every other Friday. It's sort of in line with, with our regular meetings here. And great to have you, Ankit, and very interesting projects sort of spinning out of, out of that. Thank you. Thank you. Alrighty. Anyone else want to make an announcement within the HCCC community here? Just generally speaking, we'd want it to be healthcare related as it relates to blockchain technologies. Otherwise, we'll get into our discussion. Alrighty. Okay. Well, so this is the third, in a continuing sort of series, as I mentioned earlier on, this is all about our COVID-19 virus pandemic. And really what we're doing is we're sort of turning our resources to finding ways to, to solve some of the problems that we have in this space. We've sort of brought in guests from around the world, and we're continuing to do that today. We have a couple of guest speakers that will be talking on the topic. So if we have Mark, I see Mark on the call. Good morning, Mark. So I'll hand over to you. You're a global blockchain solutions leader for healthcare and science sciences at IBM. Mark, take it away. Hi, can you hear me? Yes. Great. Good morning. Excellent. It worked. This is often the hardest part, getting, getting the online meeting to work. But thank you and good morning, everyone. Thank you for having me in your group today. Yes. I'm, my name is Mark Trashak. I'm our global solution leader for blockchain, but specific to the healthcare and life sciences industries. So that covers everything from what you would think of as patient or clinical data, all the way through to the supply chain, which is something I'm going to talk for a little bit about today. And I want to talk about a, a solution that's just launched. It's launching since soft launch now, it'll, it'll launch over the weekend. But the, the website, which is in your link, you know, you could go and see it. We call it rapid supplier connect. We call it rapid supplier connect. So this is something that's been stood up specifically for the COVID crisis. And we've MacGyvered it together from different things that IBM has in its toolkit. And MacGyver is not a legal term. So the legal folks always get upset with me when I use that. So I'm just kidding a little bit here. So what we're, what we're trying to do, you know, I'm sure that everyone has seen, you know, that care facilities and hospitals all over the US and the world, they're running out of stuff. Now we've seen these, these horrible heartbreaking images of nurses wearing garbage bags because they don't have PPE and things like that. And, you know, that's tragic. And then on the other side of that, it's magnificent that companies all over the world are kind of repositioning themselves to help meet this need, right? Because the typical or traditional supply chain makers of these, this equipment, they're, they're kind of tapped out. So what do I mean? I mean, I'm sure you've all seen the case where General Motors is making ventilators and Dyson in the UK, the vacuum company is making ventilators. And that's fantastic. And think of that as being on one end of the spectrum. And then on the other, you have things like PPE, personal protective equipment, some masks, gowns, gloves. And then you have everything in between, right? Everything in between, everything in between. And you have companies all over the world that are doing this. So, you know, more on the other side, you see companies, apparel companies like Ralph Lauren or Gap, right, spinning up to make PPE and masks. And kind of a wide range of suppliers along that continuum. And that's great, but it gets to another problem. It's if you're a hospital in, let's say, New Hampshire, you're the director of procurement in a hospital in New Hampshire, how would you ever connect to a apparel maker in Brazil, who's now making this equipment, right, that you need? Because you don't run in the same circles, right? And then let's say you do happen to find them or they find you. How do you know who they are? I mean, it could be a billion-dollar company in Brazil, just to keep using that example. And you as a buyer in a hospital would have no idea, right? So, how do we close this gap? And that's where this rapid supplier connect solution comes in. And it's designed to make it possible for buyers and suppliers, including these non-traditional suppliers, to quickly find each other and to accelerate the verifications and onboarding that need to be done. And then to gain kind of near real-time insight into their available inventory. And now we'll get into, you know, how blockchain is involved in this. So as I said, we kind of MacGyvered this together between some existing solutions. So for the supplier identity piece, right, we use a platform called Trust Your Supplier, which is live today. And if you go to the Trust Your Supplier website, you could see that. And, you know, what's involved there is that if you're a supplier, you could join this platform and you create a digital identity or wallet for yourself, right? And in this wallet, you would post kind of information and documents and certificates of compliance, all kind of things that, you know, normally go into a company establishing their bona fides that, you know, they would need to prove before a buyer would do business with them, right? So there's a process that procurement goes through to verify a supplier before onboarding them. And that process is, you know, fairly the same across all these companies. So this creates this wallet of information, these documents. And now all of this is, this is where we use blockchain because it makes an immutable record of them, right? So that there's some confidence that what is actually uploaded is the authentic information. And then any certificates or like asset stations, like a Dun and Brad Street number, all of that we could verify or validate rather using external parties, right? So a supplier creates this digital identity. This is recorded on blockchain. They're able to list the categories of medical equipment that they support. And now there are roughly 15, think of these as top-level categories, 15 categories of goods that are in need. And then they're also able to post the inventory that they have available. And this now gets into a different IBM software called Sterling Inventory Visibility. And that could accept EDI files for bigger suppliers or it could also take CSV files for smaller ones. And, you know, they could update the supplier, could update this as frequently as they like, right? So now to look at it from the other perspective, if you're a buyer, what does this do for you? So again, think back to the hospital in New Hampshire. You know, you now have a single place to go to find these alternative suppliers, right? So alternative suppliers, you have a place to go to find them. And you have a single source of truth for this critical information that you need, right, before you're willing to do business with them. And, you know, you could search the categories to find exactly what you need. Maybe you need masks, but you don't need oxygen tanks or whatnot, right? You could quickly zoom in on those categories and then see what inventory they have available, right? Now the actual transaction itself doesn't take place on this platform, right? We wanted to put something in place that was very quick and focused on an immediate need. So then to actually transact the order, you know, typically for big companies, they would be registered on one or more kind of procurement platforms, so like Arriva or Koopa or something else, right? They would then, if they're both on the same platform, they would both go off and do the transaction there, or they would do it, you know, through whatever process they cared to. And to make this easy, right, to make this easy, IBM is supporting it with people. So to help suppliers and buyers onboard quickly, we have a support team that we're standing up. And this will probably expand to other companies as well, so the IBM and others working on this. And we think, you know, it's about 30 minutes to gather the information and then, you know, for a buyer or supplier, and then once we get it in the system, it takes maybe a day to validate it, right? And then somebody would be up and running. And IBM is making this available. The buyers and suppliers, you know, during the emergency, right now we're saying for 120 days, people could come on and use the platform. And we want and we encourage people to do that. So this is, you know, now to flip to blockchain talk, this is a great example how we could bring something to bear, you know, using blockchain to fit, to fill an immediate and critical need. And this is actually, you know, in production now, right? And people will be able to use this. And we, everyone at IBM is very excited because we feel that this could really help. So let me stop there and see what questions you all have. No questions so far, but certainly I like the solution. I think the fact that you're making it available for the 120 day window is a great thing, you know, for everybody involved. And in theory, I would agree that this thing should rapidly change the availability of critical inventory items on supply chain pretty fast. So it's a big deal. Thanks. Yeah, this is Rich Mark. So are there organizations that are sort of already in the process of sort of integrating the solution, making use of the solution, particularly as it relates to? Yeah, that's a great question. And, you know, we've been soft launching this for a little while now. And part of that is getting organizations on board. And I can't because this is a public call now, I can't give specific names, but what I will do is give an example. So we've been working with an entity that's known as a paymaster. And you could think of them as an escrow agent. So what they've done is they've aggregated companies that want to manufacture, you know, that are pivoting into the space. Most of them are based in Asia. And, you know, they've aggregated the suppliers and we're onboarding all of these suppliers now. And this entity, this paymaster acts as an escrow agent optionally, right, optionally. So we have like a little trade finance bank in the platform. So what that means is again, let's say I'm on the hospital in New Hampshire and the shirt factory in Brazil, even though they're a billion dollar company, let's say they want a million dollars upfront to make the PPE. And I'm like, yeah, I don't know about this. So with the paymaster, I could give the money to the paymaster and they put it in escrow, which means they're holding it. And then when the when the items come in, you know, I go and inspect them. And if they are what, you know, they're supposed to be, I take the items and the paymaster releases the money. Right. And that's a way that we, a further way that we optionally, you know, can reduce risk to parties. Now, we've also been talking to big hospital systems in the country too, as well as group purchasing organizations. And some of them are being on board at now too. So when the press release for this goes out next week, which is really sort of the big announcement, we hope to be able to include many of these types of companies in that announcement. But, you know, we do have to have to almost sort of manifest this network into being, right, because this only works if we have buyers and suppliers. And the only way we have buyers and suppliers is if buyers and suppliers join. But we're pretty confident that that will, you know, the network will grow pretty quickly. But that's a good question. Excellent. Well, thank you, Mark. We do have to move on. But if anyone has an interest in sort of following up with Mark, I think maybe the easiest way might be to work through Erica. Erica is our vice chair for the HECIG. And I believe Erica, she worked with Mark either directly or directly. So that might be the easiest way to sort of make that happen. But again, thank you so much, Mark. I appreciate it. And I'm really excited to sort of see this coming together. Thank you. Oh, excuse me. Thank you. Thank you for having me. Thank you. Okay. So moving on. So we have Anesu Machoko. He's our CEO and co-founder for Meta-Digital. And Anesu, did you want to sort of take over? And let's hear what you have to say. I'm trying to share my screen. Can everyone see my screen? Okay. So thank you again for having me today. I'm going to talk a little bit about Meta-Digital and what we are doing. We are a pre-payment claims verification platform. But along the way, we have seen some opportunities around COVID-19 that relate to what we are doing and other utilities that we could offer to different stakeholders, big payers, or even providers. And what I really wanted to focus on, even if we go through the discussion, is not just the regulatory changes that are favorable for digital health, but also the incentives that are structured within the stakeholders, right? Why would even, it's not just important to just say we are having a solution for COVID, but what are the incentives for the doctor, for the pharmacy, for the patient to use your solution without you having to heavily incentivize it? Because that makes the difference between whether there's an early adoption or you're stuck into that cell cycle, trying to figure out how to implement your product. So we are located in San Francisco. So this is an example of the market. I think everyone knows the amount of fraud. If you estimate around 10% to be fraud, which we think is higher because of survivorship bias, you tend to see that there's a lot of fraud out there. So there's incentive. So for our solution, because there's a lot of fraud, and we figure out how much the type of fraud we can stop, our customer is the insurance company. So we'll figure it out that we are going directly to the payer and the payer will bring in other stakeholders, be it providers or labs or even patients to come on board. They'll be incentivized through the provider. So this is an example of the size of the market. So this is basically our distribution of the 390. So we kind of some of the types of fraud based on some of the guidance from HHS to kind of create four distinct buckets that we can actually break down the frequency and the severity of the types of fraud. And essentially what happens with most of the post payment verification that happens currently, essentially they're having a longer revenue billing cycle and it doesn't really stop identity theft or let's say ghost billing, right? That happens a lot. And there's an example that I'll cite with Blue Cross Blue Shield shortly. So what are some of our applications? So our applications work with prescriptions, medical claims and dental claims. And this is now very important when you think about one of the regulations the government just allowed, which is doctors can now participate doing telemedicine across deadlines. That creates a huge incentive for fraud and eliminates one of the constraints that was there. So if you go into the co-tivities of the world besides that actually do post payment claims verification, if a claim is originated by a doctor in Florida and filled in Kentucky, that's fraud 101, right? But now some of the regulations now really allow that. They allow you to interact with an out-of-state doctor and then that doctor can actually issue a prescription. Now how do we know whether that's fraudulent, whether that's actually accurate? So those are some of the challenges that payers are actually wrestling with. So we have applications for prescriptions, medical claims and dental claims. And in this case, as I give you an example, I want you to kind of like think at the end of the day, not the patient showing up at the doctor's office, but now interacting with a doctor that is actually remote, right, using telemedicine. It's the opportunity here. So what do we understand about healthcare? So healthcare right now is one of the only industries where a service is provided before any verification happens. And we tend to use the owner system. So if you think about your mortgage loans and credit cards, they all require pre-payment verification, yet all the medical claims are post payment. So we call it a pay-and-checks model. So essentially that creates loopholes that can be exploited for fraud. So what are we solving here? We're solving a lot of, a lot of verification with electronic billing, because electronic billing verifies the doctor, but not the patient or the service provided, which means that if I'm the doctor, I can change the identity of the patient or the identity of the service provided and the payer will never know. So as Rich mentioned, we had, you know, I mentioned earlier, I think in the introduction with the pilot that is scheduled in September 1st with Blue Cross Blue Shield, and I wanted to bring your attention to a problem that they resolved with about 18 months ago. It is important to note that this problem, our solution would have stopped this problem immediately. So this is a case in which ghost billing identity theft and duplicate billing happened. 500,000 fraudulent claims passed through the system and detected. And if you look at some of the effects of this story, you had a hospital going from 267 claims to 67,000, and it was caught over a nine-month period. So they clearly survived as she buyers and fraud is allowed to pass through. Now put that into the context at the back of your mind as you are watching this presentation, that's now the point of contact between you and the provider is probably going to change with COVID-19 as you are going to deal with telehealth. And now we are going to be in a position where we have to authenticate and verify claims that have been originated by doctors through telehealth. How do we have that integration? So that is something that we are actually working on right now. So how do we design our solution? I think this is pretty simple for a lot of people involved in hyperlegia, indeed, who still would understand it. Basically, we are proving confirmation, digital confirmation signatures at points of care. So this is our prescription solution. For example, the patient in this case, in pre-COVID, the patient would have shown up into the hospital and scanned a QR code, and then their information, health card and insurance information would be put into the doctor's screen. At this point, we would know the time and location when the doctor and the patient actually met. And then if you go back to this particular case study, the 500,000 fraudulent claims in this case, it actually happened that the doctor and the patient never actually met. So we would be able to stop this type of fraud because we are able to authenticate the point of contact between the physician and the patient. Our confirmation signature is established. The doctor sends the prescription to the patient's mobile phone. When the patient accepts the custody of the prescription, they are authenticating the service that they just got from the doctor and the confirmation signature is established. Then the patient will use a search function to send a prescription to the pharmacy and another confirmation signature is established. Essentially, what's happening is that we are creating consensus between the patient, the doctor and the pharmacist before that to figure out what is the time and place where the service, the point of care was administered, what is the service provided and the unique identity of the participants. So that allows us to verify the claim before pre-payment. It also allows us to stop some of the types of fraud that are very difficult for post-payment data analytics, such as cost billing or identity theft, because they tend to be very much more qualitative sometimes. There's a bit of qualitative analysis that needs to be done. Whereas with this, we are creating a secure order trail that is very cheap for post-claim administrative analysis. So now when you want to figure out who committed the claim, you know when the doctor and the patient actually met, you know when the patient sent the prescription to the pharmacy. So we have a demo, but I'll forward the slide deck afterwards because I want to be within the eight minutes. So I'll walk you through what we have, the traction, but what I wanted to kind of like mention was the distribution channel of how we are able to do this, because there's a challenge when you are coming up and trying to deal with enterprise partners. Do you go in and integrate into existing applications or do you create yourself a new marketplace? And this now falls into what I wanted to discuss about, which is the incentives of the participants. When we are thinking about our solution ourselves, we are constantly thinking about why should a payer want to use our solution. So basically from our perspective, we are able to verify every claim. We are using a deterministic method where we are actually verifying for place of connection service provided with unique signatures for everyone involved. As compared to outlier sampling, looking for initial transactions, a lot of survivorship bias. So we will capture more fraud and we'll be able to reduce the healthcare expenditures that are actually sent. So this allows us to know exactly who our customer is. So our customer is the payer. So when the payer gets the benefit, now they can go and actually incentivize the providers. But we have a shared vision with the payers and the providers. So we assist them in this. So how do they get the providers on board? One of the things is the provider or the patient doesn't really care about fraud, to be honest. They don't. They only care about making their workflow much better, whether they commit fraud or not. The doctor, the patient, do not care about fraud. The only person who cares about fraud is the employer or the insurance company which is acting as an administrator. So in this case, we have to find incentives to get some of the old providers to want to use our solution. And this is going to be very important as we design some of our solutions for COVID-19, not just coming up with a solution that is, you know, that solves the pain point, but what are the incentives for the participants to use them? So when we did our surveys with doctors, we found out that they really like to be paid a bit earlier. So because now you can verify the claim prepayment, you can reduce that revenue billing cycle from as long as, you know, 30 days to as literally as to one to two business days. And also it's a big problem with hospitals. You know, once a claim gets, you know, you know, someone protests about a claim and then it has to go for further review, that could take more than 120 days. And essentially that puts that claim into default and that affects hospital's bottom line. Reduce medical errors. We're using less manual inputs. And one of the things that happens, especially with, with, you know, paper prescriptions or other stuff is that doctors spend a lot of time trying to verify people. So now think about this scenario where you have a telemedicine, right, where the doctor is in Denver and, you know, my mom is in Florida and they're trying to interact and I have to verify the doctor, but I also have to verify the pharmacy, which, which is meant to get the prescription. And oh no, I also have to verify the patient, right. So now you are now seeing how complex it's now going to become when you now have a more, you know, a bigger population of doctors to choose from, which is not just constricted to a certain geographical area, which creates opportunities where we integrate into a, into the, with an API into the, the telehealth service, integrate into the EMR service and then also integrate into the pharmacy management network. So if they are relaying information, we are doing the verification behind the scenes. One of the things that we are seeing and that especially with COVID-19 is patient-centric solutions, faster check-ins and reducing overbilling. But one of the things that I wanted to look at is for example, pharmacies. So we have been talking to a few pharmacies ourselves. And one of the challenges that, you know, the Walgreens or the CVS is that some of the pharmacies that they deal with are franchises, right? So they're not technically under the thumb of the corporate office. They are run by other people that, and those pharmacies also are at financial risk, right? They're not going to have as many people walk into the doctor's office and they, and go into the pharmacy afterwards. So that's a business challenge. So what does that mean? It means that now the pharmacy, if they want to maintain a certain level of volume of business, they have to interact with the patient remotely using their mobile phone. And that gives us an idea of, okay, if we can make a prescription claim a credential that can be passed along with the patient, how do we incentivize one, the doctor to want to use a new workstream to send a prescription as a credential to the patient? Secondly, where would the patient actually want to care about actually having this credential into their hands? And we think that by having the patient being able to interact and connect with their doctor through the insurance patients app and interact with the pharmacies through the insurance patients app and also verify their own claim, it allows them to be in full control of every aspect of their, of their healthcare. So this is a, you know, this is the final page of my presentation. I would have said a lot of things, but I would just wanted to kind of like talk about what we are doing, but also think at the back of our minds about the incentives of the people that are going to use our solutions, right? Because that determines how it's going to be actually applied. So thank you very much. Excellent. Thank you, Anesu. So I am just a little bit mindful of time. I think my sort of, sort of big question here would be how do we relate that? I mean, this is a great workflow that we see here. How do we relate that to, to sort of the COVID virus today? Because it looks really like a compelling workflow that you. Yeah. So the way we are doing, we are working with COVID-19 addressing is we are talking to pharmacies right now, right? Because we are looking at local pharmacies or the French pharmacies that literally rely on their business model by having the doctor's office on top of that, right? People showing up and then they have prescriptions filled. And some of them do not have a relationship where they can connect with patients or their patients or, you know, they're historically their patients remotely. And we are trying to engage with, with some of the big insurance companies, but also pharmacies along the way to make sure that they can have some form of credential that allows people to interact directly with the pharmacy, knowing that when that prescription gets to the pharmacist, the pharmacy can actually authenticate the doctor, can authenticate the patient without really, you know, wasting a lot of time. So I think the pain point here is how do we cover the amount of business that the pharmacy is losing because of social distancing, people are not going out as much and allowing them to have a verifiable credential that can actually be, can be sent remotely and still have the same effectiveness. Excellent. Well, so thank you, Anesthu, so much for that. And just because I'm a little sensitive of time, I think we want to just move on and we could perhaps queue up some questions for later. Thank you again. So I want to move over to consensus health. So I know Heather isn't available to join us today, but Dr. Jonathan Holt, Jonathan, did you want to sort of speak on behalf of- Yeah, sure thing. Actually, I can have some slides to share. Okay. Let me on share here. Go ahead. Let's see. I have too many windows open. Let's try that one. Okay. So I'm Jonathan Holt. So I'm a triple board certified physician. I'm boarded in genetics, internal medicine and clinical informatics, and I'm the CMIO, the chief medical informatics officer for consensus health. And over the last three or four years, I've been, I've been deep in blockchain technologies and healthcare. And to understand that, I've actually have participated in or have ran about five hackathons. And so as I joined consensus health, I really see the role hackathons play in during a time of a crisis, such as what we're in right now. And to quote one of my colleagues, hackathons represent all the good in this world and the power of diverse teams to turn revolutionary ideas into reality. And I would also extend this to this view to deposit that during this crisis, it really demands diverse approaches to come together collaboratively to solve these hard problems and use whatever tools that we have available. I've over the last four years, you know, participating in hackathons, there's all sorts of people who bring novel ideas to the table. And I think during this crisis, I think it really is it begs for this opportunity to present those opportunities of what tools actually people are using. And I certainly see there's a there's a lot of developers who migrate to the the Ethereum platform, mostly because there's not a lot of tools there. But there's certainly I see a lot of applications using the Hyperlegion tools, including Aries, Indy, you know, I myself at one of the hackathons worked on Indy extensively. And so I think that really is an ability to work collaboratively to see what tools can help solve these several problems. And I think it's it's this time of the crisis where, you know, I don't want to people to stand by and be a helpless bystander. And my own story is that when I was 13, I saw a horrible motorcycle accident. And I stood there for about 30 minutes, you know, watching the paramedics rescue this victim. And it was that moment that I realized that I didn't want to be a helpless bystander my whole life. And it really motivated me to become a paramedic and ultimately a physician. And it is in that that that approach that we approaches this these things with a hackathon of sort of approach, which is that really is having the right attitude skills and awareness. And that is the attitude that you're not going to be helped bystander. And you have the skills to do something. And you're aware of what's wrong in the world and actually how to make it right. So which is why we've launched the hackathon to actually just sort of help think our way out and find a solution collaboratively. So I always see this as being in three major buckets for the entities are involved in helping this end during this crisis. And it also emphasizes our strategic vision from consensus. And it really boils down to information, resources and people. So information, do we have authentic, validated information? Who's at risk? Who's on the front line? What's what where the hot spots are actually happening right now? And it's amazing that we actually we don't have a good eyes on this, you know, that as far as testing, who's at risk, even just the community spread, I saw a report this morning that showed that the people who are asymptomatic are there about over 50% of people don't show any symptoms and test positive for COVID-19. And I think hence why we're actually in this, you know, global lockdown mode of really trying to contain this. But the second part of this is the resources. This gets into supply chain management, secure and trusted supplies. And then finally people, the heroes who are actually on the boots on the ground, you know, do they have what they need? Do they have the right credentials? And how are we supporting those troops on the front line? So in short, the mantra that I've been saying as far as this hackathon is data is the medicine that we need. And blockchain is yet just another tool that we can use to help automate this process of sharing authenticated information. And with that, we're adopting the Mackenzie's strategic approach, where we see five phases of this crisis. And it really has to do with first resolve. And it has to do with resolving the current crisis, containing it, mitigating it, suppressing it, but also really important to that we actually stand resolute in our mindset and tackle this crisis with the right character and to the right approach, going back to this idea that we're not going to be a victim and we're going to get out of this together to think our way out with a solution, to engineer a solution. And then second, the resilience to survive this crisis. Finally, this concept of returning to normal. And what is the new normal going to look like? Well, we're going to reimagine it. And so we're going to re engineer what the new normal is going to look like. And finally, actually, we're going to see that actualized. But it really is going to be this process of us engineering our way out of this and reimagining what the future is going to look like. And so we've actually already kicked off the hackathon. So it started this Monday and the teams are forming. And unlike other hackathons that I've participated in, we're actually stretching this out to be over two to three weeks long. And the reason being is that actually we really want some thoughtful process in some hackathons, you sort of actually like you throw together some code and you present it. And it's the it's a team with the the snazziest sort of presentation that actually like, you know, when, but really actually we want some some hard, thoughtful approaches of engineering solutions. And so I'm proud to say that Brian Bellendorf, who I think is on the call is actually going to be one of our judges as well as Joe Lubin, Alex Callahan, Debbie Bucci. And so we're and Heather Flannery, my CEO. And I think we're, you know, we're again, not it's only emphasizing the Ethereum platform, but there's so many different touchpoints, as you all know, Project Bezzo has actually been donated to the Hyperlegia Foundation, which is based on the Ethereum blockchain. And there's so many other touchpoints, including I've been heavily involved in our file credentials with the decentralized identifier specification. And so there's a lot of touchpoints with the project and work that's coming out of the Indie project, as well as the Aries cryptographic primitives coming out of the Ursa project. And so I think it really is to highlight the opportunities of touchpoints of interoperability to actually get us through this crisis. So we've actually already had some some great meetings this week to actually office hours, actually to help the developers actually to understand the tools. And like I said, the judging goes until May 11th. And we have some wonderful partners, including Hyperlegia and the other ones listed below. And with that, I'll take some questions. Well, excellent. Thank you so much, Jonathan. Yeah. Any questions? Just a quick one. Do you have a link to where the work is actually being collected that's online somewhere? I assume it's like GitHub or something like that? Yeah. So it's actually Gitcoin, which is actually a project that actually uses GitHub. And I will put the link in. And I think actually it should be in the meeting notes. I think Heather actually did give you a link to that. Yeah. Actually, there it is. Actually, it's the Stop COVID-19 Ethereum hackathon. Yeah, there we go. And we're also really, so we actually have over 60 mentors signed up for this. And so, and the mentors, if you've guys gone to a hackathon is that there's a lot of people who sort of they are great technicians and developers, but they lack the understanding of either healthcare or life sciences to understand what the problems need solving. So we've actually come up and this has actually worked well with other hackathons where we actually teamed the developers with mentors. So, so far we've had over 60 mentors sign up and we're in the process of pairing the participants with those mentors to help them understand the business and problems in healthcare that need solving. And we've done this online in a way that's just unprecedented that I think that actually it's a wonderful example of actually how we can get together to solve these hard problems. Can I ask, do you have a tracing application as part of, I'll call it the solutions you're looking at? So I'm not open to any and all. And some of the people asked like things like 3D printed ventilators, you know, could that be a solution to actually present? And I'd say, yeah, you know, hook in certainly like a 3D printed ventilator would actually need to how do you strategically share, disseminate the schemas, how do you actually get that certified, how do you actually get the ventilator to the front line. So as any sort of approach, you know, I'm agnostic to having a predetermined fixed solution. I'm really thinking about how can we actually engineer our way out of this crisis. And it really is about not certainly there's an emphasis on the Ethereum platform, but there's so many touchpoints for collaborative interoperability with all of the solutions. So there's, I guess there's I'll say at least three main areas that people have been looking at. One is the supply chain. We heard that earlier on the IBM side, but there's so many issues in there that you mentioned equipment, all kinds of stuff. So that's a huge area, but it also has a lot of focus, which is good. Here's the second area is testing, which has been a major problem in a lot of countries, including the US. And it looks like there's momentum to go the way Florida just did this week, where they said, we're going to have unlimited testing. You know, so in a sense, I don't need a doctor, I can say, gee, I think I got a fever, I can go to a drive-through location. So that, although that capability isn't there where it needs to be, if that is fully delivered, let's put it that way, then that does address a big issue there. And the last one, I think, is the current lockdown social distancing and all that can be reduced if you have better contact racing, you know, obviously. Yeah, exactly. I think so. I don't hear anything about that really. That's significant there. There's no sort of efforts that I see focused on them. Yeah, and so certainly there's opportunities abound. For instance, I'm a physician, I guess, got my emergency credentials here in Illinois to participate in the front lines. And so certainly credentialing management is an issue. I've been heavily involved in that with verifiable credentials and onboarding of physicians using like QR codes. And I think, and there is this mantra in medicine also is that, you know, you first do no harm. And so I think this is amazing technologies, but I think it's about the right implementation of technologies. But, you know, one certain opportunity for automation, like there's a form from the CDC called the person under investigation. And currently, as a physician, it takes you about a half hour to fill out the form and you have to fax it to the CDC. And so that to me is just mind-boggling and right for an innovative approach to how to ultimately just to get the right information authenticated, validated to the right people to get the right information to allocate the right resources to help fight this battle. You're right. Those are huge issues, both FDA and CDC processes that in a sense don't work the way they need to work effectively in a quick and accurate process is a big issue. But in a larger sense, I do look at this contact tracing problem this way, that effect you can remove or lower, I should say, as they said yesterday about the phases to overlap in society again, you need to be able to in a sense have effective contact tracing that makes it work easily for everyone. Yeah. So, and I think that one of the pillars I think that I was hoping to highlight is the opportunity for zero knowledge groups. And that's something that we can sense out actually a very strong approaches to. And I think it's, it's, but it really needs to be the touchpoints of interoperability. I've seen a lot of zero knowledge proof implementations, but it really is about, you know, how do you understand the zero knowledge in a way that actually is like, is there a knowledge and yet semantically interoperable? And that's, that's a whole challenge by itself. Yeah, semantic interoperability is a big issue. Absolutely. Well, thank you, Jonathan. I appreciate it very much. Any questions for any of our speakers before we sort of move on to sort of the last sort of segment as we're rolling up to the top of the hour? Alrighty, so I just wanted to close out. And first of all, thanks to all of our speakers. It's been great. Really, the value of getting our speakers sort of engaged in this discussion is to sort of shed some light on various sort of facets of how we might solve some of these problems. We heard several today, which is great. As we've over the past really month and a half or so learned a little bit more about how different organizations are approaching these sorts of problems in different ways, which is phenomenal. I think getting a little sense for how everyone sort of thinks and organizations approach this problem a little bit differently, I think is valuable as well. And this is probably a little bit more to fundamentals for some smaller organizations and startups. And actually some larger organizations as well. There's always interest in understanding funding opportunities on this page as we've been doing sort of going forward, we continue to sort of update on funding opportunities, both global and then here in the US. So feel free to read through this. I don't think we'll walk through these today necessarily, but make use of this as a resource to you and your organizations. This is all very, very good information. And of course, given the nature of the COVID virus, this is very, very dynamic as well. I will call out one point that came online very, very early this morning. And so I was able to get this on the agenda very quickly. We have a COVID help for families that the page that just kicked off. And I'll show it to you here. This is really a matchmaking opportunity, helpers versus those that need help. And so I'll have you sort of walk through that and that just came online earlier. It's not necessarily blockchain technology is specific, but it is another sort of representation of how we might think in terms of engaging sort of end points here. And I think Jonathan makes a really good point from his point of view as a physician. How do we sort of connect the dots here? And I think that's sort of our ongoing issue going forward. Alrighty, well, thanks everyone. Very much appreciated as always. And again, if you're fairly new to the organization here in the healthcare special interest group, please feel free to get yourself engaged at a more granular level. Again, we have three great subgroups that are working pretty regularly. And we also have some other opportunities within the special interest group to continue to get engaged. Very likely we'll continue with these special meeting topics because these are really, really critical. And of course, we know that this is an ongoing issue that hasn't hasn't gone away quite yet. So thanks everyone. Be safe first and foremost, and have a great weekend. And we'll see you in two weeks. Thanks everyone. Thank you.